Efficacy and safety of vardenafil in men with erectile dysfunction in general clinical practice.
- Author:
Xue-jun SHANG
1
Author Information
1. Department of Andrology, Nanjing General Hospital of Nanjing Command, Nanjing, Jiangsu 210002, China. shangxj@androl.cn
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Community Pharmacy Services;
Erectile Dysfunction;
drug therapy;
Europe;
Humans;
Imidazoles;
adverse effects;
therapeutic use;
Male;
Middle Aged;
Phosphodiesterase Inhibitors;
adverse effects;
therapeutic use;
Piperazines;
adverse effects;
therapeutic use;
Prospective Studies;
Sulfones;
adverse effects;
therapeutic use;
Triazines;
adverse effects;
therapeutic use;
Vardenafil Dihydrochloride
- From:
National Journal of Andrology
2005;11(7):556-559
- CountryChina
- Language:Chinese
-
Abstract:
Since fixed-dose vardenafil clinical trails don't fully represent utilization of phosphodiesterase-5 (PDES) inhibitor in general clinical practice. This article reviews flexible-dose and community practice studies, to assess the efficacy and safety of vardenafil in general clinical practice. The results show that vardenafil improves erectile function in most men treated for ED in clinical practice, and well tolerated.
